Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-SMS Antibody (R3M92)

Catalog #:   RHE94803 Specific References (49) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC, IP
Accession: P52788
Overview

Catalog No.

RHE94803

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200, IP: 1:100-1:200

Target

Spermine synthase, SPMSY, SMS, Spermidine aminopropyltransferase

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P52788

Applications

IHC, IP

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3M92

Data Image
  • Immunohistochemical
    IHC-P analysis of testis tissue by SMS antibody (RHE94803). IHC-P was performed using sections of the formalin-fixed paraffin-embedded testis tissue;Result: Cells in seminiferous ducts are positively stained at the cytoplasm.
  • Immunoprecipitation
    Lane 1: A-375 lysate; Lane 2: SMS immunoprecipitated from A-375 lysate by RHE94803;Lane 3: The same Lane 2 but use IgG isotype control antibody;Result: RHE94803 can immunoprecipitate SMS;
References

Persistent self-reported health complaints in Norwegians who attribute their symptoms to tick bites or tick-borne disease- a cross-sectional controlled study., PMID:40380337

Vaccine-Induced Specific Cellular and Humoral Immunity after MRNA-Based COVID-19 Vaccination in Athletes and Controls., PMID:40367509

Impact of High-Efficacy Therapies for Multiple Sclerosis on B Cells., PMID:40277931

Translation of COVID-19 Serology Test on Foil-Based Lateral Flow Chips: A Journey from Injection Molding to Scalable Roll-to-Roll Nanoimprint Lithography., PMID:40277543

Revolutionizing Treatment Strategies through Inhibition of Tissue Factor Pathway Inhibitor: A Promising Therapeutic Approach for Hemophilia Management., PMID:40200623

Epstein Barr Virus Encephalitis Treated with Intravenous Immunoglobulins and Corticosteroids., PMID:40175655

Fab-Induced Stabilization of an Ion Channel Receptor Enables Mechanistic Characterization of Small-Molecule Therapeutics., PMID:39993138

Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response., PMID:39869833

Secrets revealed by the skin: initial success of tislelizumab and targeted therapy in advanced renal cell carcinoma-a case report and literature review., PMID:39816236

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories., PMID:39772242

Demonstration of T-Cell Monotypia Using Anti-TCRbeta1/2 (TRBC1/2) Immunostaining as a Rapid and Cost-Effective Alternative to PCR-Based Clonality Studies for the Diagnosis of T-Cell Lymphoma., PMID:39594145

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial., PMID:39547252

Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial., PMID:39541562

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial., PMID:39532861

High-parametric protein maps reveal the spatial organization in early-developing human lung., PMID:39477961

Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series., PMID:39418120

Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma., PMID:39413375

Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study., PMID:39308028

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma., PMID:39293083

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial., PMID:39213421

Identification of Schistosoma haematobium and Schistosoma mansoni linear B-cell epitopes with diagnostic potential using in silico immunoinformatic tools and peptide microarray technology., PMID:39173089

Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation., PMID:39106493

Open-source, high-throughput targeted in situ transcriptomics for developmental and tissue biology., PMID:39099456

A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer., PMID:39069436

Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review., PMID:38936417

Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC., PMID:38924756

Critical peripheral ischemia: Higher prevalence in Indian systemic lupus erythematosus inception cohort for research (INSPIRE)., PMID:38922692

Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma., PMID:38899693

Vascularity evaluation of the equine tarsocrural and proximal intertarsal joint septum, and comparative analysis of two arthroscopic transection techniques., PMID:38804260

Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates., PMID:38768344

Perioperative Nivolumab in Resectable Lung Cancer., PMID:38749033

A Prospective Observational Study of Autoimmune Encephalitis in Northwestern India., PMID:38700300

The effectiveness of intervention in hepatitis C patients and improvement in their referral rate., PMID:38696817

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study., PMID:38538574

Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study., PMID:38530568

Baseline Severity and Disease Duration Can Predict the Response to Allergen-specific Immunotherapy in Allergic Rhinitis., PMID:38485909

Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up., PMID:38464059

Evaluation of immuno-histochemical markers in oral squamous cell carcinoma., PMID:38415034

Recurrent episodes of oral mite anaphylaxis in a dog., PMID:38412013

Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)., PMID:38316517

Adalimumab vs placebo as add-on to Standard Therapy for autoimmune Uveitis: Tolerability, Effectiveness and cost-effectiveness-a protocol for a randomised controlled trial (ASTUTE trial)., PMID:38267244

Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment., PMID:38266498

Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein., PMID:38247569

Metagenomic analysis of the ocular toxoplasmosis in children uveitis from Fayoum governorate, Egypt., PMID:38216107

Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation., PMID:38147543

Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE)., PMID:38082159

Gastrointestinal manifestations in systemic lupus erythematosus: data from an Indian multi-institutional inception (INSPIRE) cohort., PMID:38059606

Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin., PMID:37880696

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects., PMID:37830484

Datasheet

Document Download

Anti-SMS Antibody (R3M92).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-SMS Antibody (R3M92) [RHE94803]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only